Ginkgo Bioworks owner sells 41,172 shares for taxes

Q: How many DNA shares did Canton Barry receive from RSUs?

The report lists 76,462 Class A common shares acquired upon conversion of restricted stock units on October 16, 2026, including shares held directly by Canton Barry and shares held by his spouse.

The reported sales covered tax withholding tied to restricted-stock vesting and were described as non-discretionary.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. ten-percent owner Canton Barry reported conversion of 76,462 restricted stock units into Class A common shares on October 16, 2026. On October 19, he reported sales of 18,803 directly held shares and 22,369 shares held by his spouse, each at $10.1430 per share, to cover tax withholding obligations tied to vesting. The sales were described as non-discretionary; no Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 10 txns

Insider Canton Barry

Role 10% Owner

Sold 41,172 shs ($418K)

Approx. gross sale proceeds $418K

Type	Security	Shares	Price	Value
Sale	Class A Common Stock ^F2	18,803	$10.143	$191K
Sale	Class A Common Stock ^F2	22,369	$10.143	$227K
Exercise	Restricted Stock Units ^{F1, F3}	26,802	--	--
Exercise	Restricted Stock Units ^{F1, F4}	9,762	--	--
Exercise	Restricted Stock Units ^{F1, F3}	29,279	--	--
Exercise	Restricted Stock Units ^{F1, F4}	10,619	--	--
Exercise	Class A Common Stock ^F1	26,802	--	--
Exercise	Class A Common Stock ^F1	9,762	--	--
Exercise	Class A Common Stock ^F1	29,279	--	--
Exercise	Class A Common Stock ^F1	10,619	--	--

Holdings After Transaction: Restricted Stock Units — 116,307 contracts (Direct); Restricted Stock Units — 126,563 contracts (Indirect, By Spouse); Class A Common Stock — 356,329 shares (Direct); Class A Common Stock — 453,951 shares (Indirect, By Spouse)

Footnotes (4)

F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
F4. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.

Key Figures

Shares sold: 41,172 shares Sale price: $10.1430 per share Restricted stock units converted: 76,462 shares +2 more

5 metrics

Shares sold 41,172 shares October 19, 2026; sales to cover tax withholding obligations

Sale price $10.1430 per share October 19, 2026

Restricted stock units converted 76,462 shares Converted into Class A common shares on October 16, 2026

RSU vesting 75% Vested on October 16, 2026 under one award schedule

RSU vesting 25% To vest on January 21, 2027 under one award schedule

Key Terms

Restricted Stock Units, sell to cover, tax withholding obligations

3 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"funded by a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

tax withholding obligations financial

"to cover tax withholding obligations in connection with the vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DNA shares did Canton Barry sell, and at what price?

Canton Barry reported sales of 18,803 directly held shares and 22,369 shares held by his spouse on October 19, 2026, at $10.1430 per share. The sales covered tax withholding obligations tied to vesting and were described as non-discretionary; no Rule 10b5-1 plan is reported.

How many DNA shares did Canton Barry receive from RSUs?

The report lists 76,462 Class A common shares acquired upon conversion of restricted stock units on October 16, 2026, including shares held directly by Canton Barry and shares held by his spouse.

What was the vesting schedule for Canton Barry's DNA restricted stock units?

RSUs approved by the Compensation Committee on July 28, 2026, under one schedule vested 75% on October 16, 2026, with 25% to vest on January 21, 2027. Other RSUs vest in equal quarterly installments over the next 12 quarters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/21/2026 - 04:12 PM EDT Accepted by SEC EDGAR 10/21/2026 - 04:06 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Canton Barry

(Last)

(First)

(Middle)

C/O GINKGO BIOWORKS HOLDINGS

27 DRYDOCK AVENUE

(Street)

BOSTON

MASSACHUSETTS

02210

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	10/16/2026		M⁽¹⁾		26,802	A	⁽¹⁾	365,370	D
Class A Common Stock	10/16/2026		M⁽¹⁾		9,762	A	⁽¹⁾	375,132	D
Class A Common Stock	10/19/2026		S⁽²⁾		18,803	D	$10.143	356,329	D
Class A Common Stock	10/16/2026		M⁽¹⁾		29,279	A	⁽¹⁾	465,701	I	By Spouse
Class A Common Stock	10/16/2026		M⁽¹⁾		10,619	A	⁽¹⁾	476,320	I	By Spouse
Class A Common Stock	10/19/2026		S⁽²⁾		22,369	D	$10.143	453,951	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	10/16/2026		M⁽¹⁾			26,802	⁽³⁾	⁽³⁾	Class A Common Stock	26,802	⁽¹⁾	8,934	D
Restricted Stock Units	⁽¹⁾	10/16/2026		M⁽¹⁾			9,762	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	9,762	⁽¹⁾	107,373	D
Restricted Stock Units	⁽¹⁾	10/16/2026		M⁽¹⁾			29,279	⁽³⁾	⁽³⁾	Class A Common Stock	29,279	⁽¹⁾	9,759	I	By Spouse
Restricted Stock Units	⁽¹⁾	10/16/2026		M⁽¹⁾			10,619	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	10,619	⁽¹⁾	116,804	I	By Spouse

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.

4. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.

Remarks:

	/s/ Karen Tepichin, Attorney-in-Fact	10/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR